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Abstract
In previous work, we have demonstrated that rPTH(1-34) increases cytoplasmic calcium concentration ([Ca2 +]i) in isolated rat
enterocytes. In the present study, we have identified the sources of PTH-mediated increase in [Ca2 +]I and the implication of Ca
2 + on
hormone early signals in enterocytes isolated from young (3-month-old) and aged (24-month-old) rats. In young enterocytes, PTH raised
[Ca2 +]i in a dose-dependent manner (1 pM–100 nM). In cells from aged rats, hormone concentrations higher than physiological (z 1 nM)
were required to observe significant increases in [Ca2 +]i. Phospholipase C (PLC) inhibitors blocked the initial acute elevation of the [Ca
2 +]i
biphasic response to PTH of young enterocytes while in old cells, no effects were observed. The voltage-dependent calcium-channel blocker
(VDCC), nitrendipine, suppressed PTH-dependent changes of the sustained [Ca2 +]i phase in young and aged animals. In this study, we
analysed, for the first time, alterations in phosphatidylinositol 3-kinase (PI3K) activity and response to PTH in rat enterocytes with ageing.
Basal PI3K activity was significantly modified by ageing. Acute treatment with 10 8 M PTH increased enzyme activity, with a maximun at 2
min ( + 3-fold) in young rats and only elevated by less than 1-fold basal PI3K activity in aged animals. Hormone-induced tyrosine
phosphorylation of p85a, the regulatory subunit of PI3K, as well as the phosphorylation on Thr308 of its downstream effector Akt/PKB was
evident in enterocytes from 3-month-old rats, whereas it was greatly reduced in the cells from 24-month-old animals. Intracellular Ca2 +
chelation (BAPTA-AM, 5 AM) affected the tyrosine phosphorylation of p85a and inhibited PTH-dependent PI3K activation by 75% in
young rats and completely abolished the enzyme activity in aged animals, demonstrating that Ca2 + is required for full activation of PI3K in
enterocytes stimulated with PTH. The Thr phosphorylation of PI3K downeffector, Akt/PKB, was also fully dependent on Ca2 +. Taken
together, these results suggest that PTH regulation of enterocyte [Ca2 +]i involves Ca
2 + mobilization from IP3-sensitive stores and the influx
of the cation from the extracellular milieu, the former pathway being blunted during ageing. The data also indicates a positive role for
intracellular calcium in one of the early signals of PTH in rat enterocytes, the activation of PI3K, and that hormone regulation of PI3K
activity and Akt/PKB phosphorylation on Thr308 is impaired with ageing.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Parathyroid hormone (PTH) is an essential regulator of
calcium homeostasis [1]. PTH stimulates both adenylyl
cyclase (AC) [2] and phospholipase C (PLC) [3] as a result
of ligand binding to the heterotrimeric G-protein-coupled
PTH/PTHrP receptor [4,5]. The ability of PTH to activate
adenylyl cyclase and protein kinase A (PKA) is mediated via
the stimulatory GTP-binding protein (Gs). PTH also directs
the Gq-mediated activation of PLC and ultimately PKC [3],
release of calcium from intracellular stores [6], and activation
of calcium channels [7,8]. PTH stimulation of other signaling
pathways involving PLA2 [9] or PLD [10] has also been
described though the details are less well characterized.
Emerging evidence indicates that PTH can regulate mito-
gen-activated protein kinases (MAPK) activity in a cell-
specific and G protein type-dependent manner [11]. How-
ever, the role of G-protein-coupled receptors and their
ligands in intestinal epithelial cell signalling remains poorly
understood. More recently, we have shown that PTH
increases rat duodenal cells calcium influx, which involve
the stimulation of dihydropyridine-sensitive calcium chan-
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nels and activation of the AC/cAMP and PLC/IP3/DAG
second messenger pathways [12,13]. Furthermore, PTH
rapidly, and in a dose-dependent fashion, stimulates Src
tyrosine kinase activity and consequently downstream the
tyrosine phosphorylation of several enterocyte proteins [14],
among which two major targets of the hormone could be
immunochemically identified as PLCg and the growth-
related protein MAPK (p42/44-MAPK), also known as
extracellular signal-regulated kinases (ERK1/2) [15,16]. In
addition, recent evidence shows that cAMP and Ca2 + play a
role upstream in the signalling mechanism leading to PTH
activation of MAPK in these cells [17]. Of physiological
significance, in agreement with the mitogenic role of the
MAPK cascade, PTH increased enterocyte DNA synthesis
[17].
Many changes occur during cellular ageing, such as
decreased membrane fluidity, increased protein oxidation,
decreased DNA methylation and defects in mitogenic signal-
ling [18]. Ageing is associated with increased circulating
PTH levels [19] and decreased serum vitamin D metabolites
[20], intestinal calcium absorption [21] and bone density
[22]. Also, an age-related decline in PTH-stimulated AC
activity in both rat kidney slices and cell membranes
[23,24] has been shown. Upon ageing, reduced PTH stim-
ulation of cAMP levels [25,26] or an increase in hormone-
dependent cAMP accumulation [27] has been observed in
bone cells. In rat duodenal cells, we have obtained evidence
of alterations in PTH-signaling systems with ageing. The
hormone increased enterocyte 45Ca2 + influx, the absolute
levels of cAMP and AC activity to a greater extent in aged
than in young rats [13] whereas the early production of IP3
and DAG generated by PTH was blunted in old animals. In
enterocytes from aged rats, the hormone-induced c-Src tyro-
sine dephosphorylation, a major mechanism of c-Src activa-
tion [28,29], was also blunted and PLCg phosphorylation via
the nonreceptor tyrosine kinase c-Src was impaired [15].
Although the relative levels of p42 and p44 MAPK did not
change with age, the magnitude of PTH-dependent MAPK
phosphorylation was significantly lower in enterocytes of
aged rats compared with those of young animals [16].
The present study was undertaken to identify the sources
of PTH-mediated increase in [Ca2 +]I, the implication of
Ca2 + on hormone-dependent PI3-kinase activation and to
further examine the influence of ageing in these early
signals elicited by PTH in rat duodenal cells.
2. Materials and methods
2.1. Materials
Synthetic rat PTH (1–34), fura 2/AM, thapsigargin, neo-
mycin, Immobilon P (polyvinylidene difluoride, PVDF)
membranes and phosphatidylinositol were from Sigma
Chemical Co. (St. Louis, MO, USA). Bayer (Leverkusen,
Germany) supplied nitrendipine. Compounds U-73122 [1-(6-
((17h-3-metoxyestra-1,3,5(10)-trien-17yl) amino) hexyl)-
14-pyrrole-2,5-dione] and U-73343 [1-(6-((17h-3-metoxyes-
tra-1,3,5(10)-trien-17yl) amino)hexyl)-2,5-pyrrolidine-
dione] were obtained from Biomol Research Laboratories
Inc. (PlymouthMeeting, PA, USA). BAPTA-AM: [1,2-bis(o-
aminophenoxy) ethane-N,N,NV,NV-tetraacetic acid tetra (ace-
toxymethyl) ester] was from Calbiochem (San Diego, CA,
USA). Rabbit anti-phosphatidylinositol 3-kinase (PI3K)
(anti-p85a), anti-phospho Akt, anti-Akt and anti-phoshotyr-
osine were from Promega (Madison, WI, USA). Secondary
antibody goat anti-rabbit horseradish peroxidase-conjugated
IgG and the Super Signal CL-HRP substrate system for
enhanced chemiluminiscence (ECL, Amersham) were
obtained from Amersham Corp. (Arlington Heights, IL,
USA). Other chemicals used were of analytical grade.
2.2. Animals
Young (3–6-month-old) and aged (20–24-month-old)
male Wistar rats were fed with standard rat food (1.2%
calcium; 1.0% phosphorous), given water ad libitum and
maintained on a 12 h light–12 h dark cycle. Animals were
killed by cervical dislocation.
2.3. Duodenal cell isolation
Duodenal cells were isolated as described previously
[30]. The method employed yields preparations containing
only highly absorptive epithelial cells that are devoid of
cells from the upper villus or crypt [31]. The duodenum
was excised, washed with 0.9% NaCl and trimmed of
adhering tissue. The intestine was slit lengthwise and cut
into small segments (2 cm length) and placed into
solution A containing (in mM): 96 NaCl, 1.5 KCl, 8
KH2PO4, 5.6 Na2HPO4, 27 Na citrate, pH 7.3, for 10 min
at 37 jC. The solution was discarded and replaced with
isolation medium containing (in mM): 154 NaCl, 10
NaH2PO4, 1.5 EDTA, 0.5 dithiothreitol, 5.6 glucose, pH
7.3, for 15 min at 37 jC with continuous shaking (87
oscillations/min). The cells were sedimented by centrifu-
gation at 750 g for 10 min, washed twice with 154 mM
NaCl, 10 mM NaH2PO4, 5.6 mM glucose, pH 7.3, and
then resuspended in measurement buffer (see below). All
the steps mentioned above were performed under an
atmosphere of 95% O2/5% CO2. Cell viability was
assessed by the Trypan Blue technique. Exclusion of
the dye in >90% of the cells was observed for at least
90 min after isolation. Morphological characterization was
performed by phase-contrast microscopy. Enterocytes iso-
lated by this procedure have been shown to possess
functional characteristics of intestinal cells [31].
2.4. Measurement of intracellular calcium [Ca2+]i
Enterocytes were loaded with the fluorescence calcium
indicator fura 2/AM for 10 min at 37 jC in the dark, in
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loading buffer containing (in mM) 138 NaCl, 5 KCl, 1
MgCl2, 5 glucose, 10 HEPES [32], pH = 7.4, 1.5 CaCl2,
0.1% bovine serum albumin, 0.012% pluronic F127 and 4
AM fura 2/AM. The cell suspension was washed with
measurement buffer containing (in mM) 138 NaCl, 5 KCl,
1 MgCl2, 5 glucose, 10 HEPES, pH= 7.4, 1.5 CaCl2, in
order to eliminate unloaded dye, and maintained at room
temperature for 15 min in the dark until used. For measure-
ments of intracellular fura 2 fluorescence signals, cells were
placed into quartz cuvettes at a density of 106/ml and then
introduced into the sample compartment of a thermostati-
cally controlled (37 jC) SLM Aminco 8100 spectrofluorim-
eter (Spectronics Inc., MO, USA) under constant low-speed
stirring. Hormone and inhibitors were added directly into
the cuvette at the indicated times. Water was used as vehicle
for PTH (1–34) and verapamil while U73122, nitrendipine
and neomycin were dissolved in ethanol ( < 0.1%) and
thapsigargin in dimethylsulfoxide ( < 0.01%). Fura 2-fluo-
rescence intensity was monitored at an emission wavelength
of 500 nm by alternating the excitation wavelength between
340 and 380 nm with a dual excitation monochromator
(DMX 1100). Signals were ratioed (R = 340:380) and max-
imal (Rmax) and minimal (Rmin) intracellular dye fluores-
cence were determined by adding Triton X-100 (0.1% final
concentration) and EGTA (5 mM, pH>8.3), respectively.
This procedure ensures that the plateau phase of the
recorded changes is not due to massive release of fura into
the medium. Transformation of fluorescence signals into
[Ca2 +]i was performed according to Grynkiewicz et al. [33].
The use of Triton X-100 in the calibration procedure did not
interfere with the fluorescence signal of fura 2. Under the
present conditions of measurement, the dissociation con-
stant (Kd) for the fura 2/Ca
2 + complex was assumed to be
224 nM [34]. All saline solutions used were prepared with
deionized water.
2.5. Immunoprecipitation
Enterocytes were treated with PTH and then lysed.
Lysate aliquots (500–700 Ag protein) were incubated over-
night at 4 jC with the corresponding primary antibodies,
followed by precipitation of the complexes with protein A
conjugated with Sepharose. The immune complexes were
washed three times with cold immunoprecipitation buffer
(10 mM Tris–HCl pH 7.4, 150 mM NaCl, 1 mM EGTA, 1
mM EDTA, 0.2 mM PMSF, 0.2 mM sodium orthovanadate,
1% Triton X-100 and 1% NP40), two times with PBS and
then subjected to Western blot analysis.
2.6. Western blot analysis
Proteins were separated by one-dimensional SDS-PAGE
[35]. Briefly, samples were mixed with 2 Laemmli
sample buffer (250 mM Tris–HCl pH 6.8, 8% SDS, 40%
glycerol, 20% 2-mercaptoethanol and 0.02% bromophenol
Fig. 1. Dose– response profile of the rapid effects of PTH on [Ca2 +]i in
duodenal cells isolated from young and aged rats. Fura 2-loaded enterocytes
isolated from young (3 months) and aged (24 months) rats, three from each
age group, were incubated with different concentrations of PTH (1–34).
Intracellular calcium concentration ([Ca2 +]i) was calculated as indicated
under Materials and methods. Data are expressed as percent increase of
intracellular calcium of the control value (138F 10 and 162F 14 nM for
young and aged cells, respectively), and correspond to the value of [Ca2 +]i
at the sustained phase (5 min) of PTH response. *P < 0.001.
Table 1
Effects of the PLC inhibitors U-73122 and neomycin on PTH-induced increase of enterocyte intracellular calcium
Time (min) [Ca2 +]i (nM)
Young Aged
+U-73122 +Neomycin +U-73122 +Neomycin
0 135F 12 133F 11 136F 10 160F 13 157F 15 162F 14
1 244F 10* 134F 13 135F 12 158F 12 155F 23 161F18
2 219F 12* 162F 14* 159F 16* 161F14 162F 15 164F 14
3 241F11* 204F 18* 210F 15* 192F 12 195F 21 197F 20
4 238F 15* 240F 10* 239F 11* 243F 20* 248F 12* 250F 16*
5 240F 12* 246F 12* 248F 16* 277F 16* 281F 23* 284F 21*
Fura 2-loaded enterocytes from young (3 months) and aged (24 months) rats were preincubated in the presence or absence of U-73122 (2 AM) or neomycin
(0.5 mM) for 3 min and then exposed to 10 nM PTH. Intracellular calcium concentration ([Ca2 +]i) was measured as described in Materials and methods.
Data are expressed as means of seven independent recordingsF S.D. and correspond to the [Ca2 +]i at each indicated time.
*P< 0.001, with respect to the control (time 0), incubated with or without compound U-73122 or neomycin in the absence of PTH.
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blue) and heated for 5 min at 95 jC. Proteins (25 Ag) were
subjected to electrophoresis on 10% SDS-polyacrylamide
minigels and then transferred to Immobilon P (PVDF)
membranes. The membranes were immersed in TBS buffer
(20 mM Tris–HCl pH 7.5, 150 mM NaCl) containing 5%
skim milk for 2 h to block nonspecific binding. Anti-PI3K
(p85a), anti-phospho Akt/PKB (Thr308) or antiphosphotyr-
osine antibodies were allowed to react with the membrane
overnight at 4 jC. The membranes were then twice washed
(5 min) with TBS-T (20 mM Tris–HCl pH 7.5, 150 mM
NaCl, 0.05% Tween 20), followed by one 10-min wash with
TBS-T. The membranes were incubated with 1 Ag/ml of
peroxidase-labeled goat anti-mouse IgG antibody in TBS-T
for 1 h at room temperature. After two washes with TBS-T,
the membrane was visualized by using an enhanced chem-
iluminiscent technique (ECL), according to the manufactur-
er’s instructions. Images were obtained with a model GS-
700 Imaging Densitomer from Bio-Rad (Hercules, CA
94547, USA) by scanning at 600 dpi and printing at the
same resolution. Bands were quantified using the Molecular
Analyst program (Bio-Rad).
2.7. PI3K assay
PI3K were immunoprecipitated from control or PTH-
stimulated cells (700 Ag protein) using anti-phosphotyro-
sine. The immunoprecipitates were washed three times with
ice-cold lysis buffer and then incubated in 50 Al kinase
buffer (10 Mn Tris–HCl pH 7.4, 150 Mm NaCl, 5 mM
EDTA, 0.1 Mm Na ortovanadate) containing 0.2 mg/ml
phosphatidylinositol (PI) at 37 jC for 10 min. The assay
was initiated by adding 50 ACi [g32P]ATP (10 Ci/mmol) and
20 mM MgCl2, and terminated by adding 6 N HCl (20 Al),
and the phosphoinositol lipids were extracted with chloro-
form/methanol (2:1). The phospholipid contained in the
organic phase were recovered, dried, resuspended in chloro-
form, spotted on a silica gel 60 thin layer chromatography
plates and separated in chloroform/methanol/28% ammo-
nium hydroxide/water (120:94:4:22.6). The phosphorylated
products were visualized by autoradiography and quantified
using the Molecular Analyst program (Bio-Rad).
2.8. Statistical evaluation
Statistical significance of data was evaluated using Stu-
dent’s t-test [36] and probability values below 0.050
(P < 0.050) were considered significant. In addition, for
multiple comparisons, Bonferroni test and analysis of var-
iance were employed. Quantitative data are expressed as the
meansF S.D. from the indicated set of experiments.
3. Results
Recent studies have shown that PTH induces changes in
cytoplasmic Ca2 + levels in rat enterocytes characterized by
an almost immediate rise in [Ca2 +]i (within 30 s), rapidly
reaching a peak level, followed by a long-lasting plateau
phase and that the early Ca2 + rise is absent in aged animals
[13]. In the present study, it is shown that PTH increases
intracellular calcium levels in enterocytes in a dose-depend-
ent manner (Fig. 1). In young rats, the PTH-induced incre-
ments in [Ca2 +]i at the plateau phase (5 min) were clearly
evident within the physiological concentration range of the
hormone (1–100 pM), the response rising until 10 nM
where major differences with respect to basal [Ca2 +]i
(138F 10 nM) were reached ( + 84%). In cells from aged
animals, higher PTH concentrations (1–100 nM) were
required to observe significant changes in cytosolic Ca2 +
above basal values (162F 14 nM). The next set of experi-
ments was designed to identify the possible sources of PTH-
mediated increase in [Ca2 +]I in enterocytes. The mobiliza-
tion of Ca2 + from intracellular stores leading to a rapid
Fig. 2. Effect of the calcium channel blocker nitrendipine on the rapid
increase in enterocyte [Ca2 +]i induced by PTH. Fura 2-loaded enterocytes
isolated from young (3 months) and aged (24 months) rats, three from each
age group, were treated with 10 nM PTH (1–34) in a Ca2 +-free
extracellular medium ( +EGTA) and variations in [Ca2 +]i monitored for 2
min. Then, nitrendipine (1 M) was added to the cuvette 2 min prior to re-
addition of Ca2 + (1.5 mM) to the medium. Thapsigargin (1 AM) was added
to aged enterocytes 2 min after addition of 1.5 mM Ca2 +. Intracellular
calcium concentration ([Ca2 +]i) was calculated as described in Materials
and methods. Time traces are representative from at least six independent
[Ca2 +]i recordings.
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increase in [Ca2 +]I is one of the earliest events stimulated by
the binding of agonists to G-coupled protein receptors that
signal through Gq-mediated activation of PLC [37]. In order
to evaluate the participation of phosphoinositide hydrolysis
in PTH response, we tested whether specific PLC inhibitors
could block the increase in [Ca2 +]i induced by the hormone
in rat duodenal cells. As shown in Table 1, compound U-
73122 (2 AM), an aminosteroid which has a selective
inhibitory effect on PLC-mediated biological activities
[38], blocks the immediate rise in [Ca2 +]i when cells from
young rats were exposed to PTH, while the sustained phase
(4–5 min) was not altered, thus indicating that the initial
phase of the response to PTH of young cells is mediated by
Ca2 + mobilization from intracellular stores. The selectivity
of U-73122 action was evidenced by the observation that
compound U-73343, an inactive analog of U-73122 [38],
was not able to block hormone-induced effects on intestinal
[Ca2 +]i (not shown). In agreement with the absence of PLC
activation and IP3 release previously reported [13], the
[Ca2 +]i response induced by PTH in aged duodenal cells
was not affected by preincubation with U73122 (Table 1).
Similar results were obtained when the cells from young and
aged animals were treated in the presence of 0.5 mM
neomycin, an aminoglycoside antibiotic that binds poly-
phosphoinositides making them unavailable to PLC [39].
We then examined the effects of Ca2 +-channel inhibition on
hormone-induced increase of [Ca2 +]i. As shown in Fig. 2
(upper panel), the voltage-dependent calcium channel
blocker nitrendipine (1 AM) reduced by 75% the ability of
PTH to increase the sustained phase of [Ca2 +]i in enter-
ocytes from young animals while in old rats the calcium
channel blocker completely suppressed the hormone
response (Fig. 2, lower panel). The presence of fully
competent intracellular calcium deposits in aged cells was
evidenced by the immediate increase in cytoplasmic Ca2 +
observed after addition of 1 M thapsigargin, a sesquiterpene
that selectively liberates stored Ca2 + by inhibiting the
endoplasmic reticulum Ca2 +-ATPase [40].
Besides the generation of IP3 [13], which induces the
rapid release of Ca2 + from internal stores, PTH triggers
the activation of phosphatidylinositol-3V-kinase (PI3K) in
rat enterocytes [41]. PI3K is one of the most important
regulatory proteins involved in different signalling path-
Fig. 3. Stimulation of PI3K activity by PTH is impaired with ageing.
Enterocytes isolated from young (3 months) and aged (24 months) rats were
treated with 10 8 M PTH (1–34) for the indicated times. After cell lysis,
PI3K was immunoprecipitated, and kinase activity was determined as
described under Materials and methods. A representative image of the
phosphorylated substrate (PIP) is shown (top). MeansF S.D. of fold
activation of PI3K are plotted as a function of the duration of PTH
stimulation of cells after scanning the autoradiographic films exposed to
TLC plates from three independent experiments (bottom). *P< 0.05,
**P < 0.025 respect to the control (0).
Fig. 4. Effects of intracellular Ca2 + chelation on PTH-dependent PI3K
activity. Enterocytes isolated from young (3 months; A) and aged (24
months; B) rats were treated with 10 8 M PTH (1–34) for 2 min in the
presence or absence of BAPTA-AM (5 AM). After cell lysis, PI3K was
immunoprecipitated, and kinase activity was determined as described under
Materials and methods. A representative image of the phosphorylated
substrate (PIP) is shown (top). MeansF S.D. of fold activation of PI3K are
plotted after scanning the autoradiographic films exposed to TLC plates
from three independent experiments (bottom). *P< 0.025 respect to the
control (C).
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ways and controlling many physiological processes,
including regulation of cell growth, proliferation, survival
and differentiation. In this study, we analyzed, for the first
time, alterations in PI3K activity and response to PTH in
rat enterocytes with ageing. To that end, enterocytes
isolated from 3- and 24-month-old rats were briefly
stimulated with 10 8 M PTH, dose selected from pre-
vious studies [41], and PI3-kinase activity was measured
after immunoprecipitation of the cell lysates with anti-
phosphotyrosine. Assays with phosphatidylinositol as a
substrate revealed that basal PI3K activity is modified by
ageing ( + 1-fold) (Fig. 3). Treatment with PTH increased
enzyme activity in young rats, peaking at 2 min ( + 3-
fold) but did not substantially modified basal activity in
aged animals (less than 1-fold, 2 min). The role of
calcium in the signalling cascade leading to increase
PI3K activity by PTH in intestinal cells is not yet
characterized. We then examined the effects of the intra-
cellular Ca2 + chelator 1,2-bis(o-aminophenoxy)ethane-
N,N,NV,NV-tetraacetic acid, sodium (BAPTA-AM, 5 AM)
on hormone-induced PI3K activity. As presented above,
an optimal increase in enterocyte PI3K activity was
observed once the cells were stimulated with 10 8 M
PTH for 2 min (Fig. 3 and Ref. [41]). We thus used these
conditions to examine the effects of intracellular calcium
chelation. As shown in Fig. 4, BAPTA-AM inhibited
PTH-induced activation of PI3K by 85% in young enter-
ocytes and suppressed PTH effects in cells from old
animals. As shown in Fig. 5, incubation of young enter-
ocytes with PTH increased the level of tyrosine phosphor-
ylation of the regulatory p85a subunit of PI3K, peaked at
2 min ( + 3-fold) and reached values near basal after 15-
min exposure, with similar kinetics to those found for the
increase in kinase activity (Fig. 3). Although basal levels
of p85a tyrosine phosphorylation were greatly higher in
old enterocytes, hormone effects were diminished by
75%. We next evaluated the implication of Ca2 + in
PTH-induced tyrosine phosphorylation of p85a. To that
end, enterocytes were again stimulated for 2 min with
10 8 M PTH in the presence of BAPTA-AM (5 AM) or
EGTA (0.5 mM). Chelation of intracellular calcium or its
removal from the external medium clearly decreased
PTH-dependent P85a tyrosine phosphorylation (Fig. 6).
An important downstream effector of PI3K is the serine-
threonine kinase Akt, or protein kinase B (PKB). The effect
Fig. 5. Tyrosine phosphorylation of PI3K p85 a regulatory subunit in PTH-
stimulated enterocytes decreases with age. Enterocytes isolated from young
(3 months) and aged (24 months) were treated with 10 8 M PTH (1–34),
for the indicated times. Cell lysates were immunoprecipitated with anti-
p85a, resolved on 10% SDS-PAGE gels, followed by Western blotting with
anti-P tyrosine antibody as described under Materials and methods. Total
p85a was measured in the same immunoblot by stripping the membrane
and reincubating with anti-p85a. Representative images and bar graphs of
phospho p85a quantified by scanning densitometry of blots from three
independent experiments from young (A) and aged (B) enterocytes are
shown. *P < 0.025, **P < 0.01 with respect to the corresponding control.
Fig. 6. Calcium dependence of p85 a tyrosine phosphorylation in PTH-
stimulated enterocytes. Enterocytes isolated from 3-month-old rats were
treated with 10 8 M PTH (1–34), for 2 min in the presence or absence of
BAPTA-AM (5 AM) or EGTA (0.5 mM). Cell lysates were immunopre-
cipitated with anti-p85a as described in the legend of Fig. 5. Representative
image and bar graphs of phospho p85a quantified by scanning
densitometry of blots from three independent experiments are shown.
*P< 0.025, with respect to the corresponding control.
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of ageing in the ability of PTH to stimulate the phosphor-
ylation of Akt/PKB was therefore investigated. As shown in
Fig. 7, treatment of enterocytes from 3-month-old rats with
PTH led to the rapid (within 30 s) phosphorylation of Akt/
PKB, as determined by immunoblot analysis with an anti-
body specific for Thr308-phosphorylated Akt/PKB. The
stimulation was time-dependent being maximal at 2 min
( + 400%), after 15-min exposure of enterocytes to PTH,
Akt/PKB phosphorylation reached values near basal. Basal
values of Akt/PKB Thr phosphorylation in aged rats were
also higher than in young animals, affecting PTH-induced
Akt/PKB phosphorylation in aged enterocytes which was
greatly diminished (45% above basal levels at 2 min).
Pretreatment of cells with BAPTA-AM or EGTA prevented
PI3K-dependent Akt/PKB Thr phosphorylation (Fig. 8).
4. Discussion
This study further demonstrates that PTH plays a role in
the regulation of duodenal intracellular Ca2 + homeostasis
and provides information on the Ca2 + pools that mediate the
regulation of intestinal [Ca2 +]i. In young duodenal cells, the
hormone induced a rapid and sustained rise in cytosolic
Ca2 + levels [Ca2 +]i of rat enterocytes, which involves Ca
2 +
mobilization from endogenous stores, followed by cation
influx from the extracellular milieu finally accounting for the
sustained [Ca2 +]i phase. A similar profile of changes in
[Ca2 +]i have been observed in rat enterocytes exposed to
17h-estradiol [42], which stimulates both Ca2 + release from
intracellular stores and extracellular Ca2 + influx, and for
PTH action in other cell types [43]. In agreement with these
observations, it has been previously reported that stimulation
of rat enterocytes with PTH results in rapid activation of PI-
PLC with a concomitant generation of both IP3 and DAG
[13]. The use of specific PLC inhibitors provided additional
evidence of the involvement of IP3-sensitive stores in the
acute phase of PTH-response in young cells, while Ca2 +
entry from out of the cell through VDCC, ligand-gated Ca2 +
channels was confirmed with Ca2 + channel blockers. PTH-
Fig. 7. Ageing affects Akt/PKB phosphorylation in PTH-stimulated
enterocytes. Enterocytes isolated from young (3 months) and aged (24
months) rats were treated with 10 8 M PTH (1–34) for the indicated times.
The cells were then lysed and comparable aliquots of lysate proteins were
separated by SDS-PAGE followed by Western blotting with anti-Thr308-
phospho Akt/PKB as described under Materials and methods. Total Akt
was measured in the same immunoblot by stripping the membrane and
reincubating with anti-Akt. Representative images and bar graphs of
phospho Akt quantified by scanning densitometry of blots from three
independent experiments from young (A) and aged (B) enterocytes are
shown. *P < 0.05, **P< 0.025 with respect to the control (0).
Fig. 8. Calcium dependence of Akt/PKB phosphorylation in PTH-
stimulated enterocytes. Enterocytes isolated from 3 month-old rats were
treated with 10 8 M PTH (1–34), for 2 min in the presence or absence of
BAPTA-AM (5 AM) or EGTA (0.5 mM). The cells were then lysed and
comparable aliquots of lysate proteins were separated by SDS-PAGE
followed by Western blotting with anti-Thr308-phospho Akt/PKB as
described under Materials and methods. Total Akt was measured in the
same immunoblot by stripping the membrane and reincubating with anti-
Akt. Representative images and bar graphs of phospho Akt quantified by
scanning densitometry of blots from three independent experiments are
shown. **P < 0.025 with respect to the control.
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induced Ca2 + mobilization from the IP3-sensitive stores is
blunted in aged duodenal cells. The hormone only stimulates
the influx of extracellular Ca2 + through 12 voltage-depend-
ent Ca2 + channels. It is then possible that the PTH-induced
activation of PKA [12] and PKC, the latter activated
through DAG originated from phospholipids other than
PIP2, contribute to the modulation of Ca2 + influx in aged
rats. These results are in agreement with previous observa-
tions showing that PTH was unable to stimulate PI-PLC
activity and thus unable to generate IP3 and DAG in
enterocytes isolated from aged rats [13]. Impairment of
PI-PLC activation by the calciotropic hormone 1,25(OH)2-
vitamin D3 in enterocytes from aged rats has also been
reported [44]. Impairment of PTH-induced Ca2 + mobiliza-
tion in aged rat duodenal cells may be also the result of a
decrease in the number or affinity of the PTH receptors
linked to PLC, or alternatively due to inefficient coupling of
receptors and guanosine triphosphate (GTP)-binding pro-
teins. In this line of evidence, in duodenal cells of aged
animals, the increases required higher PTH concentrations
than for young rats. Recently, we have obtained evidence
showing that PTH stimulates PI-PLC activity in rat enter-
ocytes via coupling to Gq/11 and the expression of protein
Gq/11 decreased with ageing [45]. Additional studies are
necessary to ascertain the precise molecular basis under-
lying the regulation by PTH of cytosolic calcium levels in
rat enterocytes searching for understanding if such an
uncoupling mechanism is selective to PTH receptor or is a
common event occurring in ageing cells. Furthermore, they
may contribute to the general understanding of the patho-
physiology of ageing as cellular mechanisms that maintain
intracellular Ca2 + concentration seem to play a key role
during senescence of other cell types [46].
In this study, we analyzed, for the first time, alterations in
PI3K activity and response to PTH in rat enterocytes with
ageing. PI3K is a heterodimer comprised of one of three
catalytic isoforms and one of seven adaptor/regulatory
proteins, PI3K, once active, catalyzes the addition of a
phosphate moiety specifically to the 3V-OH position of the
inositol ring of phosphatidylinositols [47]. The resulting 3V-
phosphorylated phosphatidylinositols serve as secondary
messengers to activate many downstream signaling targets,
initiating the physiological effects of PI3K. Activation of
the dimeric p85/p110 PI3K molecule occurs through phos-
phorylation of a tyrosine residue by either receptor or
nonreceptor tyrosine kinases [48]. There are, however, other
mechanisms of PI3K activation, as direct interaction
between the PI3K catalytic subunit and one or several
cellular proteins, such as the complex formation between
p21-Ras and p110 resulting in activation of PI3K [49]. The
double-enzymatic activity of PI3K (lipid kinase and protein
kinase) as well as the ability of this enzyme to activate a
number of signal proteins including some oncoproteins
determines its fundamental significance in regulation of cell
functions such as growth and survival, ageing and malignant
transformation [47]. We show here that PI3K is rapidly and
transiently activated upon PTH treatment of young rat
enterocytes. The hormone activates PI3K inducing the
tyrosine phosphorylation of the regulatory (p85a) subunit
of PI3K. We have obtained evidence that inhibition of the
cytosolic tyrosine kinase c-Src prevented PTH-induced
phosphorylation of p85a [41]. However, how c-Src couples
the PTH receptor to PI3K in unknown at present. With
ageing, we found that PI3K activity and the tyrosine
phosphorylation of its regulatory subunit are severely
reduced in rat enterocytes. High basal levels of PI3K
activity and p85 phosphorylation in aged rats may be due
to activation of anti-apoptotic mechanisms, which control
cell survival during ageing, or could be related to mechan-
ical stress during cell isolation. It is unclear whether PI3K
activity changes during cell ageing, although a decrease in
PI3K activity was reported to cause an increase in ageing
rate in normal fibroblasts [50]. However, the mechanism of
PI3K-dependent control of cell ageing and the role of
individual effectors of PI3K are still unknown. PI3K activity
after insulin stimulation was dramatically reduced in liver
and muscle of aged rats [51] and insulin signaling defects
due to a reduced activation of PI3K and PKB with no
changes in the protein levels of the p85 subunit of PI3K has
been reported in fat cells from old rats [52]. Moreover, the
p85a subunit of PI3K in cardiac muscle declined in old
mouse whereas the skeletal muscle content of this protein
was unaffected by ageing [53].
The catalytic activity of protein and/or lipid kinase
regulation is tightly coupled to various extracellular or
intracellular signals. Alterations in the levels of intracellular
Ca2 + mediate the action of several hormones through the
regulation of key enzymes. PI3K activity may be modulated
by Ca2 + [54] through a Ca2 +-dependent interaction of
calmodulin directly with the p110 catalytic subunit of the
enzyme [55], as was also seen with the SH2 domain of the
p85 regulatory subunit [56]. Furthermore, Ca2 +-dependent
conformational changes of the N-terminal SH2 domain of
p85 were reported to be important for PI3K binding to the
PDGF receptor [57] and Ca2 + ions were found to directly
activate purified PI3-kinases in bovine thymus [58]. Our
data clearly indicate that conditions that inhibit PTH-
induced increases in [Ca2 +]i suppressed, to a great extent,
hormone stimulation of PI3K activity and the tyrosine
phosphorylation of its regulatory subunit. We have recently
reported that PTH-induced increases in cytosolic Ca2 +
stimulate the tyrosine phosphorylation of the MAPKs
ERK1 and ERK2 [59] and that PI3K is also required for
ERK1/2 activation in rat enterocytes [60]. Therefore, it is
likely that calcium may play a central role in PI3K-modu-
lation of the MAPK pathway in intestinal cells.
One of the best characterized PI3K effectors is the
serine–threonine protein kinase Akt(PKB), whose activa-
tion following growth factor or cytokine stimulation is
directly dependent on PI3K-derived phosphorylated phos-
phatidylinositols [61]. The PI3K effector Akt has been
implicated, either directly or indirectly, in the phosphor-
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ylation and subsequent regulation of several transcription
factors [62]. We show here that Akt is also transiently
activated by PTH in young rat enterocytes, as measured by
Western blot analysis of Thr308-phosphorylated Akt, with
similar kinetics of PI3K activation by the hormone. Fur-
thermore, hormone phosphorylation of Akt/PKB was fully
dependent on calcium. Phosphorylation of Thr308 by PDK1
in the presence of PIP2 and/or PIP3 is a prerequisite for
kinase activation, but phosphorylation of the C-terminal
hydrophobic residue Ser473 is required as well for full
activation of Akt kinase [63]. With ageing, PTH-stimula-
tion of Akt/PKB is greatly diminished, probably because
the system might be near maximal turn on as indicated by
the high basal PI3K activity as well as p85 and Akt/PKB
phosphorylation. The reasons for the higher basal levels
detected in enterocytes from aged rats in comparison to
young animals are unclear. Insulin-dependent Akt/PKB
phosphorylation was also reduced in muscle tissue and
unchanged in liver of aged rats [64] and reduced expres-
sion of Akt/PKB was observed in senescent cardiac
fibroblasts [65]. Of physiological significance, very recent
studies revealed that PI3K is necessary for the functional
and morphological differentiation of intestinal epithelial
cells [66]. Therefore, as a result of impaired activation of
PI3K with ageing, PTH regulation of many biological
process such as cell proliferation and differentiation may
be altered.
In summary, our results demonstrate that PTH regula-
tion of enterocyte [Ca2 +]i involves Ca
2 + mobilization from
IP3-sensitive stores and the influx of the cation from the
extracellular millieu, the former pathway being blunted
during ageing. The data also indicates a positive role for
intracellular calcium in one of the early signals of PTH in
rat enterocytes, the activation of PI3K, and that hormone
regulation of PI3K activity and the phosphorylation on
Thr308 of its downeffector Akt/PKB is impaired with
ageing.
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